SIRT3 and leukemia: 3-TYP is a highly potent SIRT3 inhibitor that was originally recognized to have certain anticancer effects in leukemia, non-small cell lung cancer and colorectal cancer, and has been widely used in the researches of various cancer due to its powerful inhibition of deacetylation activity of SIRT3 31.